Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 48
Filtrar
1.
Nucl Med Commun ; 43(6): 625-630, 2022 Jun 01.
Artículo en Inglés | MEDLINE | ID: mdl-35362693

RESUMEN

Keloid, hypertrophic scars and basal cell carcinoma (BCC) falls under the category of non-melanoma skin cancer. Intralesional steroids, external beam radiation therapy, 5-Fluorouracil, cryotherapy, laser, etc are the available treatment options. However, recurrence has been reported with each type of treatment mode. In the present article, various treatment modes have been discussed and institutional experience of Rhenium-188 skin patches for the treatment of keloids and BCC has been discussed.


Asunto(s)
Cicatriz Hipertrófica , Queloide , Medicina Nuclear , Anomalías Cutáneas , Cicatriz Hipertrófica/patología , Cicatriz Hipertrófica/terapia , Crioterapia , Humanos , Queloide/diagnóstico por imagen , Queloide/radioterapia , Anomalías Cutáneas/terapia
2.
Am J Med Genet A ; 185(7): 2150-2152, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33836117

RESUMEN

Poikiloderma with neutropenia (PN), is a rare autosomal recessive condition with many associated complications and manifestations. Here we present a patient with confirmed PN who is of one-quarter Chucktaw or Cherokee heritage with no known descent from the Navajo tribe. The patient's condition was complicated by chronic bilateral lower limb cellulitis and associated osteomyelitis which was unresponsive to extensive antibiotic regimens. Subsequent treatment with hyperbaric oxygen therapy (HBOT) was successful. To date, no author has reported on the treatment of recurrent cellulitis using HBOT in this patient population. Based on our experience, HBOT should be considered in patients with PN.


Asunto(s)
Celulitis (Flemón)/terapia , Oxigenoterapia Hiperbárica/métodos , Neutropenia/terapia , Osteomielitis/terapia , Anomalías Cutáneas/terapia , Adulto , Celulitis (Flemón)/genética , Celulitis (Flemón)/fisiopatología , Femenino , Humanos , Neutropenia/genética , Neutropenia/fisiopatología , Osteomielitis/genética , Osteomielitis/patología , Anomalías Cutáneas/genética , Anomalías Cutáneas/fisiopatología , Adulto Joven
3.
Am J Med Genet A ; 185(2): 625-630, 2021 02.
Artículo en Inglés | MEDLINE | ID: mdl-33258232

RESUMEN

Self-improving dystrophic epidermolysis bullosa is a rare subtype of dystrophic epidermolysis bullosa (DEB) characterized by significant improvement in skin fragility within the first few years of life. Genetic inheritance has previously been reported as autosomal dominant or recessive with both forms harboring mutations in COL7A1. To date, there have been no reports of this rare clinical entity from various Southeast Asian ethnicities. Here, we describe the clinical and molecular features of five patients from the Southeast Asia region who presented with predominantly acral-distributed blisters and erosions in the first few days of life. Blistering resolved over several months, without appearance of new blisters. By immunofluorescence, intraepidermal retention of Type VII collagen was observed in all patient skin biopsies when investigated with antibody staining. Genetic analysis of four patients revealed pathogenic variants in COL7A1 which have not been previously reported. The clinical diagnosis in these rare patients is confirmed with molecular histology and genetic characterization.


Asunto(s)
Colágeno Tipo VII/genética , Epidermólisis Ampollosa Distrófica/genética , Predisposición Genética a la Enfermedad , Anomalías Cutáneas/genética , Asia Sudoriental/epidemiología , Biopsia , Preescolar , Epidermólisis Ampollosa Distrófica/diagnóstico , Epidermólisis Ampollosa Distrófica/fisiopatología , Epidermólisis Ampollosa Distrófica/terapia , Femenino , Humanos , Lactante , Recién Nacido , Masculino , Anomalías Cutáneas/diagnóstico , Anomalías Cutáneas/fisiopatología , Anomalías Cutáneas/terapia
4.
Acta Derm Venereol ; 100(5): adv00053, 2020 02 12.
Artículo en Inglés | MEDLINE | ID: mdl-32039456

RESUMEN

The term skin fragility disorders describes a group of conditions in which the structural integrity of the skin is compromised and its resistance to external shear forces diminished. Skin fragility can have different causes, ranging from genetic variations to inflammatory or physical phenomena. The genetic skin fragility disorders, collectively called epidermolysis bullosa, serve as a paradigm for the study of causes and mechanisms of skin fragility. Recent biomedical research has revealed substantial genetic heterogeneity of the epidermolysis bullosa group, delivered ample new knowledge on its pathophysiology, and facilitated the design of evidence-based therapeutic strategies. The therapy development process extends from in vitro testing to preclinical validation in animal models, and clinical trials. This article reviews different approaches to curative and symptom-relief therapies, and appraises their status and perspectives for clinical implementation.


Asunto(s)
Epidermólisis Ampollosa/genética , Epidermólisis Ampollosa/terapia , Predisposición Genética a la Enfermedad , Terapia Genética/métodos , Anomalías Cutáneas/genética , Anomalías Cutáneas/terapia , Tratamiento Basado en Trasplante de Células y Tejidos/métodos , Manejo de la Enfermedad , Epidermólisis Ampollosa/patología , Medicina Basada en la Evidencia , Femenino , Predicción , Alemania , Humanos , Masculino , Índice de Severidad de la Enfermedad , Anomalías Cutáneas/patología , Resultado del Tratamiento
5.
Clin Exp Dermatol ; 45(2): 141-146, 2020 Mar.
Artículo en Inglés | MEDLINE | ID: mdl-31529496

RESUMEN

Vascular anomalies can cause both emotional and physical distress to patients, particularly children. The paediatric laser service at Great Ormond Street Hospital (GOSH) treats a range of dermatological conditions including a variety of vascular anomalies, excess hair growth and disfiguring scars. The laser team at GOSH has 25 years of experience in treating a wide variety of paediatric dermatological conditions using various laser therapies. With over 600 new referrals for laser therapy and over 1000 laser procedures each year the GOSH laser team has vast amounts of experience with both common and rare conditions. Excellent clinical outcomes continue to be delivered, and new treatment therapies are constantly being developed to treat more recalcitrant lesions. The adverse effect rates experienced by the GOSH laser patients have been decreasing over the past two decades, reaching the low rate of 0.8% per treated patients per year. This remarkable achievement has been continuously improved by integrating specific and standardized laser protocols for each patient treated, to ensure efficacious and safe laser treatment delivery. Treating vascular anomalies with laser therapy creates significant positive results among the paediatric population, thus laser therapy at GOSH makes a significant impact upon children's lives with both rare and common vascular anomalies.


Asunto(s)
Terapia por Láser , Anomalías Cutáneas/terapia , Malformaciones Vasculares/terapia , Niño , Preescolar , Femenino , Hemangioma/terapia , Humanos , Terapia por Láser/efectos adversos , Terapia por Láser/métodos , Masculino , Síndromes Neurocutáneos/terapia
7.
Am J Med Genet A ; 179(6): 915-926, 2019 06.
Artículo en Inglés | MEDLINE | ID: mdl-30868735

RESUMEN

Mutations in the CHRNG gene cause autosomal recessive multiple pterygium syndrome (MPS). Herein we present a long-term follow-up of seven patients with CHRNG-related nonlethal MPS and we compare them with the 57 previously published patients. The objective is defining not only the clinical, histopathological, and molecular genetic characteristics, but also the type and degree of muscle involvement on whole-body magnetic resonance imaging (WBMRI). CHRNG mutations lead to a distinctive phenotype characterized by multiple congenital contractures, pterygium, and facial dysmorphism, with a stable clinical course over the years. Postnatal abnormalities at the neuromuscular junction were observed in the muscle biopsy of these patients. WBMRI showed distinctive features different from other arthrogryposis multiple congenita. A marked muscle bulk reduction is the predominant finding, mostly affecting the spinal erector muscles and gluteus maximus. Fatty infiltration was only observed in deep paravertebral muscles and distal lower limbs. Mutations in CHRNG are mainly located at the extracellular domain of the protein. Our study contributes to further define the phenotypic spectrum of CHRNG-related nonlethal MPS, including muscle imaging features, which may be useful in distinguishing it from other diffuse arthrogryposis entities.


Asunto(s)
Anomalías Múltiples/diagnóstico , Anomalías Múltiples/genética , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad , Hipertermia Maligna/diagnóstico , Hipertermia Maligna/genética , Mutación , Fenotipo , Receptores Nicotínicos/genética , Anomalías Cutáneas/diagnóstico , Anomalías Cutáneas/genética , Anomalías Múltiples/terapia , Adolescente , Alelos , Sustitución de Aminoácidos , Biopsia , Preescolar , Ecocardiografía , Femenino , Estudios de Asociación Genética/métodos , Pruebas Genéticas , Genotipo , Humanos , Imagen por Resonancia Magnética , Masculino , Hipertermia Maligna/terapia , Modelos Moleculares , Músculo Esquelético/diagnóstico por imagen , Músculo Esquelético/patología , Conformación Proteica , Receptores Nicotínicos/química , Anomalías Cutáneas/terapia , Relación Estructura-Actividad , Imagen de Cuerpo Entero
8.
BMC Ophthalmol ; 18(1): 252, 2018 Sep 18.
Artículo en Inglés | MEDLINE | ID: mdl-30227830

RESUMEN

BACKGROUND: To report a patient who presented with bluish scleral discoloration, keratoconus, and progressive high myopia. CASE PRESENTATION: A 6-year-old Chinese female patient presented with a significant bluish discoloration of the sclera in both eyes and extreme corneal thinning with anterior corneal protrusion. General pediatric physical examination was normal for all systems and no genetic disorders known were observed. CONCLUSIONS: We aim to highlight the importance of diagnosis and treatment of patients suffering from Brittle cornea syndrome. Timely diagnosis and early provision of protective glasses seem to be the most important step in treating BCS. To our knowledge, this is the first case of BCS being reported in the Asia area.


Asunto(s)
Anomalías del Ojo/patología , Inestabilidad de la Articulación/congénito , Anomalías Cutáneas/patología , Niño , Diagnóstico Diferencial , Anomalías del Ojo/terapia , Dispositivos de Protección de los Ojos , Anteojos , Femenino , Humanos , Inestabilidad de la Articulación/patología , Inestabilidad de la Articulación/terapia , Queratocono/patología , Miopía Degenerativa/patología , Esclerótica/patología , Anomalías Cutáneas/terapia
9.
Rev. méd. Minas Gerais ; 28: [1-5], jan.-dez. 2018.
Artículo en Portugués | LILACS | ID: biblio-970385

RESUMEN

Micose fungoide é uma neoplasia dos linfócitos T helper que afeta a pele e geralmente não apresenta manifestações extracutâneas por muitos anos. Já a micose fungoide hipocromiante (MFH) corresponde a um subtipo daquela com melhor prognóstico e que se apresenta com lesões hipocrômicas a acrômicas, com distribuição mais comum em tronco, regiões proximais de extremidades e cintura pélvica. O diagnóstico é firmado pela apresentação clínica aliada à histopatologia, que evidencia epidermotropismo com linfócitos atípicos. A doença geralmente apresenta boa resposta ao tratamento, o qual pode ser realizado com fototerapia com raios ultravioleta A (UVA), ultravioleta B (UVB), mostarda nitrogenada tópica, carmustina tópica e irradiação cutânea com elétrons. Descreve-se o caso de uma criança com máculas hipocrômicas que surgiram inicialmente no abdome, posteriormente se estendendo para raiz de coxas e região inguinal. As lesões apresentavam descamação fina, porém sem eritema ou prurido e ausência de linfonodomegalia palpável. A princípio o caso foi conduzido como eczemátide hipocromiante, mas o paciente apresentou agravamento importante das lesões em poucos meses apesar do tratamento, sendo assim, aventada a hipótese diagnóstica de MFH. Duas biópsias de pele foram realizadas, e os exames anatomopatológico e imunohistoquímica evidenciaram certo epidermotropismo, mas sem atipia de linfócitos. Foi orientado helioterapia domiciliar, com exposição corporal de 10 minutos no período da manhã, além do uso de emolientes e cuidados gerais com a pele, com relativa boa resposta. O acompanhamento é semestral e caso haja modificação do quadro, a biópsia com estudo histopatológico e a imunohistoquímica serão realizados novamente. (AU)


Mycosis fungoides is a type of cancer of the T helper lymphocytes that affects the skin and generally has no extracutaneous manifestations for many years. Otherwise, hypopigmented mycosis fungoides corresponds to a subtype with better prognosis and presents as hypopigmented or achromatic lesions, with more widespread distribution in the trunk, proximal parts of extremities and pelvic girdle. The diagnosis is confirmed by clinical presentation and histopathology, which shows epidermotropism and atypical lymphocytes. The disease usually show good response to treatment, which is performed with phototherapy with ultraviolet A (UVA), ultraviolet B (UVB), topical nitrogen mustard, topical carmustine and cutaneous irradiation with electrons. We describe the case of a child with hypochromic taint that initially appeared in the abdomen, later extending to root thighs and groin. The lesions had fine scaling, absence of erythema or itching, without the presence of palpable lymph node enlargement. At first the case was conducted as pytiriasis alba, but the patient had significant aggravation of injuries in a few months in spite of the treatment, thus mooted diagnosis of hypopigmented mycosis fungoides. Two skin biopsies were performed, and the histological and immunohistochemical tests showed epidermotropism but no atypia of lymphocytes. It was guided home heliotherapy, with body exposure of 10 minutes in the morning, besides the use of emollients and general skin care, with a relatively good response. The follow-up is bi-annually and if there is a modification in the condition, the biopsy with histopathological study and immunohistochemistry will be performed again. (AU)


Asunto(s)
Humanos , Terapia Ultravioleta/estadística & datos numéricos , Micosis Fungoide/radioterapia , Linfoma , Anomalías Cutáneas/terapia , Micosis Fungoide/tratamiento farmacológico , Terapéutica/métodos , Niño
10.
11.
Rev. argent. cir. plást ; 23(1): 21-26, 20170000. fig
Artículo en Español | LILACS, BINACIS | ID: biblio-1391795

RESUMEN

La piel es asiento frecuente de injurias en especial traumáticas o neoplásicas, surgiendo la necesidad de la reconstrucción de la brecha quirúrgica. Existen múltiples opciones de reconstrucción y su uso dependerá del tamaño del defecto quirúrgico a reparar y de la experiencia y preferencia del cirujano tratante. Presentaremos al colgajo romboidal de Limberg y sus variantes como una técnica reconstructiva de gran utilidad para cubrir defectos cutáneos en cara y otras partes del cuerpo respetando la función y estética de la región.


The skin is a frequent seat of injuries especially traumatic or neoplastic, arising the need for reconstruction of the surgical gap. There are multiple reconstruction options and their use will depend on the size of the surgical defect to be repaired and on the experience and preference of the treating surgeon. We will present the rhombus Limberg fl ap and its variants as a reconstructive technique of great utility to cover skin defects in the face and other parts of the body respecting the function and aesthetics of the region.


Asunto(s)
Anomalías Cutáneas/terapia , Colgajos Quirúrgicos/trasplante , Procedimientos de Cirugía Plástica/métodos , Procedimientos Quirúrgicos Dermatologicos/métodos
12.
Eklem Hastalik Cerrahisi ; 27(3): 171-4, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27902173

RESUMEN

Escobar (multiple pterygium) syndrome is progressive and a very rare syndrome. It is generally characterized by multiple pterygia that are found in the cervical, antecubital and popliteal regions. In this report, we present the treatment management of a 14-year-old case with late stage Escobar syndrome who was admitted due to multiple pterygia and bilateral knee contractures. The treatment of this case was conducted in collaboration with the department of orthopedics and the department of physical therapy. The treatment of the case was done in three stages: soft tissue procedures, femoral recurvatum osteotomy and triple arthrodesis, respectively. In addition to all these, the patient did intensive physical therapy for one year. As a result of the operations and physical therapy, adequate muscle strength was obtained.


Asunto(s)
Anomalías Múltiples/diagnóstico , Anomalías Múltiples/terapia , Comunicación Interdisciplinaria , Colaboración Intersectorial , Hipertermia Maligna/diagnóstico , Hipertermia Maligna/terapia , Anomalías Cutáneas/diagnóstico , Anomalías Cutáneas/terapia , Adolescente , Terapia Combinada , Humanos , Turquía
14.
Sci Rep ; 6: 27315, 2016 06 06.
Artículo en Inglés | MEDLINE | ID: mdl-27265476

RESUMEN

Non-coding RNAs provide additional regulatory layers to gene expression as well as the potential to being exploited as therapeutic tools. Non-coding RNA-based therapeutic approaches have been attempted in dominant diseases, however their use for treatment of genetic diseases caused by insufficient gene dosage is currently more challenging. SINEUPs are long antisense non-coding RNAs that up-regulate translation in mammalian cells in a gene-specific manner, although, so far evidence of SINEUP efficacy has only been demonstrated in in vitro systems. We now show that synthetic SINEUPs effectively and specifically increase protein levels of a gene of interest in vivo. We demonstrated that SINEUPs rescue haploinsufficient gene dosage in a medakafish model of a human disorder leading to amelioration of the disease phenotype. Our results demonstrate that SINEUPs act through mechanisms conserved among vertebrates and that SINEUP technology can be successfully applied in vivo as a new research and therapeutic tool for gene-specific up-regulation of endogenous functional proteins.


Asunto(s)
Productos Biológicos/administración & dosificación , Regulación de la Expresión Génica/efectos de los fármacos , Enfermedades Genéticas Ligadas al Cromosoma X/terapia , Terapia Genética/métodos , Microftalmía/terapia , ARN Largo no Codificante/administración & dosificación , Anomalías Cutáneas/terapia , Animales , Productos Biológicos/metabolismo , Modelos Animales de Enfermedad , Humanos , Oryzias , ARN Largo no Codificante/genética , ARN Largo no Codificante/metabolismo , Resultado del Tratamiento
15.
Del Med J ; 88(10): 308-310, 2016 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-29894032

RESUMEN

The patient is a unique case presenting with presumed Restrictive Dermopathy (RD) and intracranial and adrenal calcifications, an association not previously described in the literature. This case postulates the possibility of additional radiographic features that can be included in the spectrum of RD or as secondary events from the underlying pathophysiology of RD.


Asunto(s)
Acidosis , Contractura/congénito , Cuidados para Prolongación de la Vida/métodos , Anomalías Musculoesqueléticas/diagnóstico por imagen , Radiografía/métodos , Sepsis , Anomalías Cutáneas/diagnóstico , Acidosis/diagnóstico , Acidosis/etiología , Acidosis/terapia , Contractura/complicaciones , Contractura/diagnóstico , Contractura/fisiopatología , Contractura/terapia , Resultado Fatal , Femenino , Edad Gestacional , Humanos , Recién Nacido , Convulsiones/etiología , Convulsiones/terapia , Sepsis/etiología , Sepsis/fisiopatología , Sepsis/terapia , Anomalías Cutáneas/complicaciones , Anomalías Cutáneas/fisiopatología , Anomalías Cutáneas/terapia , Ultrasonografía/métodos
16.
Rev Med Brux ; 36(4): 348-57, 2015 Sep.
Artículo en Francés | MEDLINE | ID: mdl-26591323

RESUMEN

INTRODUCTION: Vascular anomalies, which are erroneously categorized under the term angiomas, are a highly heterogeneous group of lesions that are poorly understood and affect a mean of 5 to 10 % of children. The fortuitous discovery of propranolol's efficacy in one of these entities has made them a topical issue. OBJECTIVES: The paper's main objective is to inform family doctors of the various types of vascular anomalies, clarify their classification, and provide a common terminology. Its secondary objective is to provide a decision tree that enables primary care doctors to avoid diagnostic pitfalls, successfully detect cases, and optimize management. METHODS: Systematic review. CONCLUSIONS: According to a recent study, 71,3 % of publications use the term hemangioma erroneously, regardless of the authors' field. The key for family doctors is to use one international classification only, that of the International Society for the Study of Vascular Anomalies (ISSVA), in order to facilitate management and comprehension between the different healthcare levels. The diagnosis of vascular anomalies is clinical in 90 % of cases, so all family doctors can, whilst using a decision tree, diagnose a vascular anomaly and refer only those that are complex for specialist care. The most common vascular anomaly is infantile hemangioma in infants, which spontaneously regresses around the age of 5-7 years in 90 % of cases. Watchful waiting and regular follow-up suffice, therefore, in such settings.


Asunto(s)
Anomalías Cutáneas , Enfermedades Cutáneas Vasculares , Malformaciones Vasculares , Niño , Preescolar , Hemangioma/clasificación , Hemangioma/diagnóstico , Hemangioma/terapia , Humanos , Anomalías Cutáneas/clasificación , Anomalías Cutáneas/diagnóstico , Anomalías Cutáneas/epidemiología , Anomalías Cutáneas/terapia , Enfermedades Cutáneas Vasculares/clasificación , Enfermedades Cutáneas Vasculares/diagnóstico , Enfermedades Cutáneas Vasculares/epidemiología , Enfermedades Cutáneas Vasculares/terapia , Neoplasias Cutáneas/clasificación , Neoplasias Cutáneas/diagnóstico , Neoplasias Cutáneas/terapia , Malformaciones Vasculares/clasificación , Malformaciones Vasculares/diagnóstico , Malformaciones Vasculares/epidemiología , Malformaciones Vasculares/terapia
17.
Gac Med Mex ; 151(5): 648-54, 2015.
Artículo en Español | MEDLINE | ID: mdl-26526479

RESUMEN

A previously healthy, immunocompetent 67-year-old female presented with a one-month history of general symptoms, weight loss, night fevers, and bilateral lower extremity edema. On admission she had severe anemia, acute kidney injury, and multiple lymphadenopathies. An excisional biopsy of one of the axillary lymphadenopathies confirmed hyaline-vascular Castleman's disease. This rare disease is a polyclonal lymphoproliferative disorder that affects the normal lymph node architecture. According to its location it can be divided in unicentric (localized) or multicentric disease; it can be further divided according to histopathology in hyaline-vascular or plasmatic cells variety. Clinical presentation relates more to histopathological variety than to centricity. Human herpes virus 8 is ubiquitous in this disease and, along with interleukin 6, plays an important role in pathogenesis and symptoms presentation. Surgery is the go-to treatment of localized disease, while systemic chemotherapy is the option in multicentric disease. Communication between the clinical and anatomopathological teams is crucial; lag in diagnosis can lead to futile investigations in search of other diseases and delay in treatment.


Asunto(s)
Enfermedad de Castleman/complicaciones , Diarrea/complicaciones , Enfermedades Hereditarias del Ojo/complicaciones , Enfermedades Intestinales/complicaciones , Anomalías Cutáneas/complicaciones , Enfermedades Vasculares/complicaciones , Anciano , Enfermedad de Castleman/diagnóstico , Enfermedad de Castleman/terapia , Diarrea/diagnóstico , Diarrea/terapia , Enfermedades Hereditarias del Ojo/diagnóstico , Enfermedades Hereditarias del Ojo/terapia , Femenino , Humanos , Inmunocompetencia , Enfermedades Intestinales/diagnóstico , Enfermedades Intestinales/terapia , Anomalías Cutáneas/diagnóstico , Anomalías Cutáneas/terapia , Enfermedades Vasculares/diagnóstico , Enfermedades Vasculares/terapia
18.
Hautarzt ; 65(12): 1022-9, 2014 Dec.
Artículo en Alemán | MEDLINE | ID: mdl-25298254

RESUMEN

Unusual congenital or early-onset skin lesions on the scalp often pose a diagnostic challenge particularly as the clinical evaluation may be hampered by dense hair growth. Thus, this paper provides a concise review on developmental abnormalities and nevi with exclusive or predominant scalp localization. Aplasia cutis congenita occurs as an isolated finding, in association with genetic syndromes, nevi and anomalies or as a consequence of intrauterine trauma and teratogens. A hairless area with a narrow surrounding rim of hypertrichosis (hair collar sign) may point to occult cranial dysraphism, especially if accompanied by further suggestive signs as port-wine stains, large hemangiomas, dimples, congenital dermoid cysts, and sinuses. Many diverse entities may hide behind cutis verticis gyrata with the primary essential form being rare and representing a diagnosis of exclusion. In contrast to former belief, benign adnexal tumors arise in a nevus sebaceus considerably more often than basal cell carcinomas and other malignant epithelial tumors. Provided that tumor development is not suspected, excision of a nevus sebaceus nevus is indicated primarily for aesthetic-psychosocial reasons. However, surgical treatment is considerably easier in small children. Nevus sebaceus may be a cutaneous marker for several complex syndromes whereas nevus psiloliparus presents almost always in connection with encephalocraniocutaneous lipomatosis. Congenital melanocytic nevi of the scalp tend toward clinical regression, so that surgical intervention in large lesions should be carefully considered. In contrast, the threshold for excision of blue nevi and other conspicuous melanocytic nevi on the scalp should be low, especially since they are difficult to monitor.


Asunto(s)
Neoplasias de Cabeza y Cuello/diagnóstico , Nevo/diagnóstico , Cuero Cabelludo/patología , Anomalías Cutáneas/diagnóstico , Neoplasias Cutáneas/diagnóstico , Diagnóstico Diferencial , Neoplasias de Cabeza y Cuello/congénito , Neoplasias de Cabeza y Cuello/terapia , Humanos , Nevo/congénito , Nevo/terapia , Anomalías Cutáneas/terapia , Neoplasias Cutáneas/congénito , Neoplasias Cutáneas/terapia
19.
Mol Ther ; 22(5): 929-39, 2014 May.
Artículo en Inglés | MEDLINE | ID: mdl-24468915

RESUMEN

Autologous human keratinocytes (HK) forming sheet grafts are approved as skin substitutes. Genetic engineering of HK represents a promising technique to improve engraftment and survival of transplants. Although efficacious in keratinocyte-directed gene transfer, retro-/lentiviral vectors may raise safety concerns when applied in regenerative medicine. We therefore optimized adeno-associated viral (AAV) vectors of the serotype 2, characterized by an excellent safety profile, but lacking natural tropism for HK, through capsid engineering. Peptides, selected by AAV peptide display, engaged novel receptors that increased cell entry efficiency by up to 2,500-fold. The novel targeting vectors transduced HK with high efficiency and a remarkable specificity even in mixed cultures of HK and feeder cells. Moreover, differentiated keratinocytes in organotypic airlifted three-dimensional cultures were transduced following topical vector application. By exploiting comparative gene analysis we further succeeded in identifying αvß8 integrin as a target receptor thus solving a major challenge of directed evolution approaches and describing a promising candidate receptor for cutaneous gene therapy.


Asunto(s)
Ingeniería Genética , Terapia Genética , Péptidos/genética , Anomalías Cutáneas/terapia , Proteínas de la Cápside/genética , Dependovirus/genética , Vectores Genéticos , Humanos , Integrina alfa5/genética , Queratinocitos/metabolismo , Queratinocitos/patología , Péptidos/uso terapéutico , Anomalías Cutáneas/genética , Anomalías Cutáneas/patología , Transducción Genética , Tropismo
20.
Mol Ther ; 22(4): 752-61, 2014 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-24434934

RESUMEN

Fragile skin, susceptible to decubitus ulcers and incidental trauma, is a problem particularly for the elderly and for those with spinal cord injury. Here, we present a simple approach to strengthen the skin by the topical delivery of keratinocyte growth factor-1 (KGF-1) DNA. In initial feasibility studies with the novel minimalized, antibiotic-free DNA expression vector, NTC8385-VA1, the reporter genes luciferase and enhanced green fluorescent protein were delivered. Transfection was documented when luciferase expression significantly increased after transfection. Microscopic imaging of enhanced green fluorescent protein-transfected skin showed green fluorescence in hair follicles, hair shafts, and dermal and superficial epithelial cells. With KGF-1 transfection, KGF-1 mRNA level and protein production were documented with quantitative reverse transcriptase-polymerase chain reaction and immunohistochemistry, respectively. Epithelial thickness of the transfected skin in the KGF group was significantly increased compared with the control vector group (26 ± 2 versus 16 ± 4 µm) at 48 hours (P = 0.045). Dermal thickness tended to be increased in the KGF group (255 ± 36 versus 162 ± 16 µm) at 120 hours (P = 0.057). Biomechanical assessment showed that the KGF-1-treated skin was significantly stronger than control vector-transfected skin. These findings indicate that topically delivered KGF-1 DNA plasmid can increase epithelial thickness and strength, demonstrating the potential of this approach to restore compromised skin.


Asunto(s)
Factor 7 de Crecimiento de Fibroblastos/genética , Técnicas de Transferencia de Gen , Terapia Genética , Anomalías Cutáneas/genética , Administración Tópica , Animales , ADN/administración & dosificación , ADN/genética , Factor 7 de Crecimiento de Fibroblastos/administración & dosificación , Humanos , Ratones , Plásmidos/administración & dosificación , Anomalías Cutáneas/terapia , Cicatrización de Heridas/genética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA